Breast Cancer Topics
The On-Topic Netowork

Breast Cancer > Advanced (Metastatic) Breast Cancer

The following information is about Advanced (Metastatic) Breast Cancer.

Advanced (Metastatic) Breast Cancer Defined

A stage of cancer in which the disease has spread from the breast to other body systems by traveling through the lymphatic system or through the bloodstream.

This definition is in context to Breast Cancer. See more contextual defintions for Advanced (Metastatic) Breast Cancer.


Navigation: [ 1 2 Next ]

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Published August 27, 2008, 3:12 pm, News-Medical-Net

Novartis has announced that Gleevec (imatinib mesylate) tablets, (known as Glivec (imatinib) outside the US, Canada and Israel), has been granted priority review status by the US Food and Drug Administration (FDA) as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors (GIST).

Full Story


Ask the Doctor at Saint John"™s: What is Tranlsational Breast Cancer Research?

Published August 27, 2008, 10:08 am, Santa Monica Mirror

A. By Xiaojiang Cui, Ph.D., assistant professor of molecular biology at the John Wayne Cancer Institute at Saint John’s Health Center, specializing in biochemical engineering, molecular biology and hormone control of breast cancer development.

Full Story


Health Buzz: Skin Cancer and Other Health News

Published August 27, 2008, 9:17 am, US News & World Report

Uninsured rates fall, Michelle Obama’s speaking finesse, and a new book from a former ER doctor

Full Story


Cytokinetics Announces Completion of Interim Safety Analysis in Ongoing Phase IIa Clinical Trial of CK-1827452

Published August 27, 2008, 4:30 am, Marketwire via Yahoo! Finance

Cytokinetics, Incorporated announced the completion of a protocol-defined interim analysis in an ongoing Phase IIa clinical trial evaluating the safety of CK-1827452 in patients with ischemic cardiomyopathy and angina. Based on the Safety Review Committee's review of safety data from the first cohort of patients, the Committee has recommended that the company open the second cohort of this ...

Full Story


Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After ...

Published August 27, 2008, 4:00 am, PR Newswire via Yahoo! Finance

Novartis announced today that Gleevec® tablets* has been granted priority review status by the US Food and Drug Administration as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors .

Full Story


If Medicine Is So High-Tech, Why So Much Illness?

Published August 26, 2008, 3:10 pm, US News & World Report

A fine new book by a former emergency doc asks tough questions gently.

Full Story


New Trial To Evaluate Nexavar® As Adjuvant Therapy In Liver Cancer

Published August 26, 2008, 6:15 am, Medical News Today

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. announced the start of a Phase III study with Nexavar® (sorafenib) tablets in liver cancer. The randomized, double-blind, placebo-controlled study is evaluating Nexavar as an adjuvant therapy for patients with hepatocellular carcinoma (HCC), or primary liver cancer.

Full Story


Randomized Phase 2 Study of IMC-A12 and IMC-1121B for Advanced Prostate Cancer Commences Patient Enrollment

Published August 26, 2008, 6:00 am, Centre Daily Times

ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed Phase 2 clinical trial in patients with advanced prostate cancer randomized to treatment with either IMC-A12 or IMC-1121B plus mitoxantrone and prednisone has commenced patient enrollment. IMC-A12 and IMC-1121B are ...

Full Story


Randomized Phase 2 Study of IMC-A12 and IMC-1121B for Advanced Prostate Cancer Commences Patient Enrollment

Published August 26, 2008, 4:00 am, Business Wire via Yahoo! Finance

NEW YORK----ImClone Systems Incorporated , a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed Phase 2 clinical trial in patients with advanced prostate cancer randomized to treatment with either IMC-A12 or IMC-1121B plus mitoxantrone and prednisone has commenced patient enrollment.

Full Story


Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to Be Presented at the European Society of ...

Published August 25, 2008, 1:00 pm, Marketwire via Yahoo! Finance

Cytokinetics, Incorporated announced today that additional interim results from an ongoing Phase IIa clinical trial of CK-1827452 are scheduled to be presented as a poster presentation at the European Society of Cardiology Congress 2008, to be held August 30-September 3, 2008 at the Messe MĂĽnchen GmbH in Munich, Germany. The trial is evaluating an intravenous formulation of CK-1827452, a novel ...

Full Story


Navigation: [ 1 2 Next ]

Are you looking for additional Breast Cancer > Advanced (metastatic) Breast Cancer news? Try our new "Advanced (metastatic) Breast Cancer News Focus" area.

Social bookmarks are not available at the moment.

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Advanced (Metastatic) Breast Cancer. If you would like to find related tags we recommend Tag Patterns > Advanced (Metastatic) Breast Cancer

Off-site Advanced (metastatic) Breast Cancer Research Links

If you still need additional information on Advanced (metastatic) Breast Cancer then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Breast Cancer

If you know the Breast Cancer Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Breast-Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a